Cluj-Napoca / Houston / Budapest / Philadelphia / Beirut / Aberdeen / Johannesburg / Freudenheim / Lahore / New York / /
Company
Aberdeen Breast Group / Novartis / Breast Health Global Initiative Systemic Therapy Focus Group / Zielinski S. Press / Wiley InterScience / Pfizer Inc. / New York Times / GE Healthcare / F. HoffmannLa Roche AG / BristolMyers Squibb Company / Fleming / LG / Bristol-Myers Squibb Company / Systemic Therapy Focus Group / North Central Cancer Treatment Group / Ethicon Endo Surgery Inc. / Intergroup / F. Hoffmann-La Roche AG / AstraZeneca / /
Continent
Europe / /
Country
Hungary / Netherlands / South Africa / Kenya / France / Pakistan / Romania / United States / Lebanon / /
Currency
pence / / /
Event
FDA Phase / /
Facility
M. D. Anderson Cancer Center / Stanford University / Cancer Institute / American University / Bergonie Institute / Anderson Cancer Center / US National Cancer Institute / Milan Cancer Institute / American University of Beirut Medical Center / Allama Iqbal Medical College / Sandton Oncology Center / / /
IndustryTerm
therapy for locally advanced breast cancer / breast cancer therapy / treatment for inoperable breast cancer / therapy for breast cancer / treatment of breast cancer / therapy for primary breast cancer / treatment of operable breast cancer / Cancer Prevention / pharmaceutical development / treatment for large operable breast cancer / breast healthcare / Cancer Treatment / breast cancer care / pharmaceutical / Breast Cancer Treatment / treatment for operable / locally advanced disease / treatment of postmenopausal breast cancer / treatment of HER2-amplified metastatic disease / therapy of breast cancer / treatment of LABC and primary operable breast cancer / satellite nodules / Chronic Disease Prevention / /
MedicalCondition
large / operable tumors / primary breast tumors / Residual disease / Labastida S. Breast carcinoma / primary breast cancer / HER2/neu-overexpressing tumors / estrogen receptor-positive breast cancer / early breast cancer / locally advanced tumors / inoperable disease / slow-growing tumors / operable and inoperable breast cancer / triple-negative tumors / nonmetastatic breast cancer / metastatic disease / Breast Disease / ER-negative tumors / postmenopausal breast cancer / operable / large tumors / breast cancer / estrogen receptor-positive breast cancers / inflammatory and recurrent tumors / tumor / locally advanced breast cancer / Cancer / tumors / regional lymphadenopathy / Clin Breast Cancer / C-erbB-positive tumors / invasive breast cancer / large primary tumors / residual tumors / T2 tumors / inoperable breast cancer / T3 tumors / low-resource settings PST downstages tumors / HER2-positive breast cancer / clinical tumor / receptor-positive primary breast cancer / ERpositive breast cancer / cost-effective breast cancer / locally advanced disease / stage I-IIA breast cancer / Locally Advanced Breast Cancer LABC / invasive cancer / HER2-amplified metastatic disease / T4 tumors / J Cancer / persistent disease / hormone receptor-positive breast cancer / regional metastases / locally advanced stage tumors / metastatic breast cancer / operable breast carcinoma / hormone-responsive tumors / operable stage IIIA disease / inflammatory carcinoma / breast cancers / disease / inflammatory breast cancer / operable disease / III breast cancer / hormone-sensitive non-metastatic breast carcinomas / HER2-negative locally advanced breast cancer / aggressive and more advanced disease / ER-positive tumors / large operable breast cancer / operable breast cancer / noninvasive cancer / aggressive tumors / /
World Health Organization / Division of Hematology-Oncology / US government / Department of Internal Medicine / Allama Iqbal Medical College / office of International Affairs / American Society of Clinical Oncology / Lance Armstrong Foundation / Bergonie Institute / African Union / American Cancer Society / Beirut Medical Center / Institut Bergonie Bordeaux Groupe Sein / Fred Hutchinson Cancer Research Center / University of Texas / National Cancer Institute / American Joint Committee on Cancer / Sandton Oncology Center / Department of Breast Medical Oncology / National Center for Chronic Disease Prevention and Health Promotion / US Agency for Healthcare Research and Quality / Stanford Comprehensive Cancer Center / American Joint Committee on Cancer TNM / office of Women / US Food and Drug Administration / Stanford University / Department of Breast Tumors / Department of Oncology / office of Research / Division of Cancer Prevention and Control / Department of Health and Human Services / Cancer Institute / American University of Beirut / Milan Cancer Institute / US Centers for Disease Control and Prevention / Oncology Nursing Society / /
Person
Robert W. Carlson / Jose Miquel Reyes / Susan G. Komen / Ion Chiricuta / Christy Russell / Chao Clifford / Valero V / Gabriel N. Hortobagyi / Ann Oncol / Jose Bines / Nagi S. El Saghir / Ahmed Elzawawy / Daniel Vorobiof / Eduardo Cazap / Richard Love / Nagi El Saghir / B. Preoperative / / /
2315 Guidelines for International Breast Health and Cancer Control–Implementation Supplement to Cancer